TABLE 4.
Extract | Doses | Route | Model | Activity | Country | Effects | Reference |
---|---|---|---|---|---|---|---|
Aerial parts | |||||||
Hydro-alcoholic | 100–300 mg/kg | Intraperitoneal injection | Male Sprague–Dawley rats | Anti-inflammatory | Venezuela | Analgesic effect on inflammatory cutaneous and deep muscle pain | Ávila-Peña et al. (2007) |
Leaves | |||||||
Hydroethanolic | 400 mg/kg | Oral | Gastric injury induced by HCL/ethanol to rats | Anti-ulcerogenic | Brazil | Reduction of the subcronic ulcer | Donatini et al. (2009) |
Ethanolic | 400 mg/kg | Oral | Rats, induced with acute inflammation | Anti-inflammatory | Bangladesh | Acute anti-inflammatory activity | Hossain et al. (2016) |
Methanolic | 200 mg/kg | Oral | Rats, CCl4 acute induced hepatic injury | Hepatoprotective | Egypt | The extract decreased the levels of all measured liver makers, including ALT, AST, TB, TC, TG, and MDA, while increasing GSH and SOD. | Sobeh et al. (2018) |
200 μg/ml | Juglone induced oxidative stress | Caenorhabditis elegans | Antioxidant | Decrease the intracellular ROS level in a dose dependent manner by 59.22%, the survival activity was also very low and dose dependent | |||
Methanolic | 100–200 mg/kg | Oral | Paracetamol-induced hepatic damage in Wistar albino rats | Hepatoprotective | - | The extract cased a significant decrease in the serum hepatic enzyme levels, SGOT, SGPT, ALKP, and serum Bilirubin in dose-dependent manner | Selvam et al. (2013) |
Ethanolic | 300 mg/kg | Intraperitoneal injection/oral | Rats, CCl4 induced hepatic injury | Hepatoprotective | Bangladesh | Gradual normalization of serum markers enzyme (SGPT, SGOT, ALP), total bilirubin, total protein, and liver weight | Islam et al. (2012) |
Methanolic | 250 mg/kg | NS | Rats, Ethylene glycol-induced urolithiasis model | Antiurolithiatic | India | reduced the phosphorus, calcium, urea, and creatinine levels in the serum | Deka et al. (2021) |
Ethanolic | 500 μg/ml | NS | S. cerevisiae (wild type and mutant strain) | Antioxidant | India | H2O2 scavenging potential | Rajkumari et al. (2018b) |
Decoction | 220 mg/kg | Oral | C57BL/J ob/ob Mice | Hypoglycemic | Puerto Rico | Better blood glucose modulation over time | Gavillán-Suárez et al. (2015) |
Bark | |||||||
Aqueous | 100–200 mg/kg | Oral | Streptozotocin–induced diabetes in rats | Antidiabetic | Egypt | Protective effects against STZ-induced diabetes | Mahmoud et al. (2021) |
Improvement in glycemic parameters | |||||||
Suppression of pancreatic oxidative stress, inflammation, apoptosis, and insulin signaling pathway in the liver | |||||||
Fruit | |||||||
Pectic polysaccharides | 150, 250 mg/kg | Intraperitoneal injection | Mice bearing Ehrlich solid tumor | Antitumor | Brazil | Reduced tumor growth and improved the body weight of tumor bearing mice | Tamiello et al. (2018a) |
Ns: Not specified.